FDA Inspection 1099772 — Advancing Sight Network Southeast Regional Office
The FDA completed an inspection of Advancing Sight Network Southeast Regional Office on July 25, 2019 in Montgomery, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 25, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Montgomery, AL (United States)